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INTRODUCTION
Trichomonas vaginalis is a protozoan parasite that infects the
urogenital tract of humans. It is one of the most common caus-
es of non-viral sexually transmitted diseases in the world [1]. T.
vaginalis infection typically elicits aggressive local cellular im-
mune responses with inflammation of the vaginal epithelium
and exocervix in women and the urethra of men [2]. This inflam-
matory response induces the recruitment of leukocytes, includ-
ing HIV target cells, such as CD4+-bearing lymphocytes and
macrophages to which HIV can bind and gain access [3-5]. 
However, few studies have reported how macrophages showed
immune responses against T. vaginalis infection. Our previous
experiments showed that natural cell-mediated cytotoxicity against
T. vaginalis is mediated by macrophages in vitro, cytotoxicity by
lymphokine-activated peritoneal macrophages increased more
than non-activated peritoneal macrophages, and their nitric
oxide (NO) plays an important role in the host defense against
T. vaginalis [6-9]. 
Macrophages are expected to come to infection loci later than
the first attacker, neutrophils, against extracellular parasites, in-
cluding T. vaginalis. During the infection progress, a limited num-
ber of immune cells could not defend against proliferating tri-
chomonads. Macrophages have been presumed to attack tri-
chomonads remaining in the infection loci and to be involved
in inflammatory reactions. However, it was not previously known
whether macrophages have an influence on vaginal inflamma-
tion.
We suggest that human macrophages may be involved in
vaginal inflammation by T. vaginalis via proinflammatory cyto-
kine and NO production. In addition, trichomonad-triggered
proinflammatory TNF-αproduction might be regulated by NO.
In this study, we examined proinflammatory cytokine and NO
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Abstract: Trichomonas vaginalis commonly causes vaginitis and perhaps cervicitis in women and urethritis in men and
women. Macrophages are important immune cells in response to T. vaginalis infection. In this study, we investigated
whether human macrophages could be involved in inflammation induced by T. vaginalis. Human monocyte-derived
macrophages (HMDM) were co-cultured with T. vaginalis. Live, opsonized-live trichomonads, and T. vaginalis lysates in-
creased proinflammatory cytokines, such as TNF-α, IL-1β, and IL-6 by HMDM. The involvement of nuclear factor (NF)-κB
signaling pathway in cytokine production induced by T. vaginalis was confirmed by phosphorylation and nuclear transloca-
tion of p65 NF-κB. In addition, stimulation with live T. vaginalis induced marked augmentation of nitric oxide (NO) produc-
tion and expression of inducible NO synthase (iNOS) levels in HMDM. However, trichomonad-induced NF-κB activation
and TNF-αproduction in macrophages were significantly inhibited by inhibition of iNOS levels with L-NMMA (NO synthase
inhibitor). Moreover, pretreatment with NF-κB inhibitors (PDTC or Bay11-7082) caused human macrophages to produce
less TNF-α. These results suggest that T. vaginalis stimulates human macrophages to produce proinflammatory cytokines,
such as IL-1, IL-6, and TNF-α, and NO. In particular, we showed that T. vaginalis induced TNF-αproduction in macrophages
through NO-dependent activation of NF-κB, which might be closely involved in inflammation caused by T. vaginalis.
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production by human macrophages stimulated with T. vaginalis.
MATERIALS AND METHODS
Reagents
Histopaque 1077 and PDTC were purchased from Sigma (St.
Louis, Missouri, USA). Dextran T500 was supplied by Pharmacia
(Uppsala, Sweden). Fetal calf serum (FCS), horse serum, and
Iscove’s DMEM (IMDM) were bought from Gibco BRL (Gai-
thersburg, Maryland, USA). LPS was from List Biological Labo-
ratories (Campbell, California, USA). Goat anti-mouse IgG and
Cy3-conjugated anti-mouse antibodies (Ab) were from Jackson
ImmunoResearch (Baltimore, Maryland, USA). M-CSF (recom-
binant human macrophage colony stimulating factor) (Bio-
Source, Camarillo, California, USA), L-NMMA (NG-Monomethyl-
L-arginine monoacetate salt) (Calbiochem, San Diego, Califor-
nia, USA), Bay11-7082 (BioMol, Plymouth Meeting, Pennsyl-
vania, USA), rabbit anti-phospho NF-κB p65 Ab (Cell Signaling,
Danvers, Massachusetts, USA), mouse anti-phospho NF-κB p65
Ab, mouse anti-inducible NO synthase (iNOS) Ab (Santa Cruz,
California, USA), and Vectashield mounting medium with DAPI
(Vecta Labs, Burlingame, California, USA) were used.
T. vaginalis culture and trichomonal lysate preparation
T. vaginalis isolate (T016) was grown in a complex trypticase-
yeast extract-maltose (TYM) medium supplemented with 10%
heat-inactivated horse serum. T. vaginalis lysates were prepared
by harvesting during the log phase of T. vaginalis growth, soni-
cating in 0.1 M PBS, and centrifuging at 10,000 g for 1 hr at 4℃.
The resulting supernatants were passed through a 0.22 μm fil-
ter [10]. To make opsonized trichomonads, live T. vaginalis was
treated with 5% human plasma for 1 hr. 
Human monocytes-derived macrophages (HMDM)  
Human polymorphonuclear leucocytes (PMNs) and mono-
cytes were isolated from peripheral venous blood drawn from
healthy volunteers as previously described [10]. Briefly, mono-
nuclear cells were separated by centrifugation on a Histopaque
1077 density gradient and plated at 5 × 106 cells/ml IMDM
supplemented with 10% human and M-CSF (10 ng/ml). Non-
adherent cells were removed after 2 hr, and macrophages were
cultured for 3 days in IMDM containing 10% human plasma
and M-CSF (10 ng/ml). The medium was changed every 3 days.
For all experiments, cells were cultured for 6-8 days, and then
used as HMDM. Cell viability was determined using the trypan
blue exclusion test (> 99%). Monocytes were detached by scrap-
ing with a rubber policeman, and their purity (~ 95%) was exa-
mined by phenotypic analysis using flow cytometry (FACSCali-
bur, Becton Dickinson, San Jose, California, USA) after staining
with fluorescein isothiocyanate (FITC)-conjugated anti-human
CD14 Ab.
Cytokine production by macrophages stimulated with 
T. vaginalis
Human macrophages were reacted with T. vaginalis (live trcho-
monads, lysate, opsonized trichomonads) for 6 hr or 24 hr. The
culture supernatants were centrifuged to remove particle debris
and stored in aliquots at -70℃. Cytokine concentrations of TNF-
α, IL-6, and IL-1βin the culture supernatants were determined
by ELISA using a BD TNF-α, IL-6, and IL-1βOptEIA set (BD Bio-
sciences, San Diego, California, USA) according to the instruc-
tions provided by the manufacturers.
Western blot analysis for pNF-κB p65 and iNOS
After human macrophages were coincubated with live tricho-
monads (macrophages : trichomonads = 5 : 1) for 1 hr (iNOS)
or 2 hr (NF-κB), cells (2 × 106) were lysed with ice-cold lysis
buffer, i.e., 20 mM Tris-HCl (pH 7.5), 60 mM β-glycerophos-
phate, 10 mM EDTA, 10 mM MgCl2, 10 mM NaF, 2 mM DTT,
1 mM Na3VO4, 1 mM APMSF, 1% NP-40, leupeptin (5 μg/ml),
2 mM levamisol, pepstatin A (10 μg/ml), 0.5 mM benzamidine,
and 1 tablet of complete Mini� (protease inhibitor cocktail) (Ro-
che, Indianapolis, Illinois, USA). Lysed samples were mixed with
SDS-PAGE sample buffer and boiled at 100℃ for 5 min. The
total cellular proteins were subjected to 15% SDS polyacrylamide
gel and electrophoretically transferred to a PVDF membrane.
The blots were incubated with rabbit anti-phospho NF-κB p65
monoclonal Ab (1 : 100) or mouse anti-iNOS monoclonal Ab
(1 : 100) as a primary Ab, and anti-rabbit horseradish peroxi-
dase-conjugated IgG or anti-mouse horseradish peroxidase-con-
jugated IgG (Amersham Pharmacia, Uppsala, Sweden) as a sec-
ondary Ab. The protein band detection was performed with ECL
plus kits as described by the manufacturer (Amersham Phar-
macia). 
Immunofluorescent staining of NF-κB p65 
The localization and translocation of NF-κB p65 in HMDM
grown on coverslips was determined by immunofluorescence
assay. After coincubation of HMDM and live trichomonads for
30 min, macrophages were fixed with 4% paraformaldehyde
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for 15 min, permeabilized with 0.5% Triton X-100 for 10 min.
Coverslips were then incubated overnight at room temperature
in mouse anti-phospho NF-κB p65 monoclonal Ab (1 : 50). Cells
were then washed and incubated in Cy3-conjugated anti-mouse
Ab for 90 min. The cover slips were mounted in anti-fade mount-
ing medium with DAPI to visualize the nucleus. Fluorescence
was measured using the fluorescence microscope (Nikon, Tokyo,
Japan). 
Transient transfection and luciferase reporter gene assays
THP-1 cells cultured in RPMI medium in the presence of 10%
FBS were induced to become an adherent, matured macrophage-
like phenotype by the addition of 10 ng/ml phorbol 12-myris-
tate 13-acetate (PMA) to the culture for 72 hr. PMA-treated adher-
ent THP-1 cells were washed 3 times and cultured in fresh medium.
The PCH110 and PGL3 NF-κB promoter constructs were trans-
fected into THP-1 cells with LipofectAmine 2000 (Invitrogen,
Carlsbad, California, USA). Luciferase activity was assayed with
a luciferase assay kit (Promega, Madison, Wisconsin, USA). Cell
extracts obtained from THP-1 stimulated with live trichomon-
ads for 1 hr were prepared in 500 μl of 1 × reporter lysis buffer.
Lysates were centrifuged at 13,000 g for 5 min and supernatants
were used to measure luciferase activity with a Luminometer
(Turner Biosystems, Sunnyvale, California, USA).
Nitrite production
The concentration of NO in culture supernatants was deter-
mined as nitrite using Griess reagent as described previously [9].
Detection of TNF-αmRNA by RT-PCR
After HMDM coincubated with live T. vaginalis for 30 min,
mRNA expressions of TNF-αwas measured by RT-PCR [11].
Total RNA was extracted from cells using Trizol reagent (Invi-
trogen) according to the method described previously [11]. Pri-
mer sequences and PCR conditions used for amplification of
β-actin and TNF-αwere as follows: β-actin (sense) 5′-CCAGAG-
CAAGAGAGGTATCC-3′, (antisense) 5′-CTGTGGTGGTGAAGC-
TGTAG-3′; PCR conditions of initial DNA denaturation at 95℃
for 10 min and 30 rounds of denaturation (95℃ for 45 sec),
annealing (58℃ for 2.5 min), and extension (72℃ for 1 min).
TNF-α(sense) 5′-ACT CTT CTG CCT GCT GCA CTT TGG-3′,
(antisense) 5′-GTT GAC CTT TGT CTG GTA GGA GAC GG-3′;
PCR conditions of initial DNA denaturation at 95℃ for 2 min
and 31 rounds of denaturation (94℃ for 30 sec), annealing
(55℃ for 30 sec), and extension (72℃ for 1 min). The PCR
products were electrophoresed in 2% agarose gel containing
0.5 μg/ml ethidium bromide and photographed under ultravi-
olet light. The band intensity was quantified using the Quantity
One program (BioRad, Hercules, California, USA) [12].  
Pretreatment of macrophages with pharmacological
inhibitors
The HMDM and THP-1 cells were pretreated with NO syn-
thase inhibitor (L-NMMA) or NF-κB inhibitors (PDTC, Bay11-
7082) for 30 min or 60 min, and then reacted with live tri-
chomonads. Expressions of TNF-αof the both macrophages
were measured by ELISA and/or RT-PCR.
Statistical analysis
Data are expressed as means±SEM of 3-4 independent exper-
iments and were analyzed with Mann-Whitney U-test. Significant
difference was accepted at a P-value of < 0.05.
RESULTS
When T. vaginalis (T. vaginalis lysate, opsonized trichomon-
ads, or live trichomonads) was coincubated with human mono-
cyte-derived macrophage monolayer (HMDM) for 6 hr or 24
hr, TNF-α, 1L-1β, and IL-6 showed increased levels compared
with untreated macrophages. The cytokine amount was gener-
ally increased with each trichomonads in dose- and time-depen-
dent manner. The TNF-αconcentration at 6 hr of coincubation
showed increased levels than those of 24 hr. The live and opso-
nized trichomonads strongly stimulated HMDM to produce
higher level of cytokines than T. vaginalis lysate. IL-6 showed
increased levels regardless of the incubation time (Fig. 1). 
Next, we examined involvement of NF-κB in the cytokine pro-
duction by HMDM. When human macrophages were stimulat-
ed with live T. vaginalis, increased phospho p65 NF-κB activity,
and translocation of NF-κB p65 into nucleus were observed by
western blot and fluorescent microscopy, respectively (Fig. 2). 
Whether NO is involved in cytokine production by HMDM
stimulated with trichomonads, NO levels were measured by the
Griess reagent. After 24 hr of coincubation, T. vaginalis, particu-
larly live trichomonads, caused macrophages to produce signif-
icantly increased levels of NO. The iNOS expression of HMDM
activated with live trichomonads was also increased 6 times more
than untreated macrophages, and showed decreased levels by
pretreatment with NO synthase inhibitor, L-NMMA by western
blot (Fig. 3). Then, we investigated whether NO could influence
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NF-κB activity. When L-NMMA, NO synthase inhibitor-pretreat-
ed HMDM was coincubated with live trichomonads, decreased
phospho NF-κB p65 activities, compared with untreated macro-
phages, were observed in HMDM or THP-1 by western blot and
NF-κB luciferase assay, respectively (Fig. 4). Also, NO synthase
inhibitor was expected to induce decreased production of cyto-
kines by macrophages. TNF-αmRNA and protein expressions
were significantly decreased by pretreatment with L-NMMA com-
pared to the untreated group, examined by RT-PCR and ELISA,
respectively (Fig. 5). Therefore, TNF-αproduction might be regu-
lated by NO. Human macrophages (THP-1 and HMDM) show-
ed decreased production of TNF-αon stimulation of live T. vagi-
nalis by pretreatment with NF-κB inhibitor, such as PDTC or
Bay11-7082, or NO synthase inhibitor, L-NMMA (Fig. 6).
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Fig. 1. Trichomonas vaginalis stimulates human monocyte-deriv-
ed macrophages (HMDM) to produce proinflammatory cytokines.
Human macrophages (1.25 × 106/well of 96-well culture plate) were
incubated with live trichomonads (1, 5, and 10 × 104), opsonized
trichomonads (1, 5, and 10 × 104) and T. vaginalis lysate (10 and
100 μg/ml). Cell culture supernatant was harvested after 6 hr and
24 hr of incubation, and analyzed for levels of TNF-α, IL-1β, and IL-
6 using cytokine-specific ELISA. *P < 0.05 versus untreated macro-
phages. 
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Fig. 2. NF-κB activation induced by Trichomonas vaginalis (T) in human macrophages (M). (A) Phosphorylation of NF-κB p65 expression
in human macrophages reacted with T. vaginalis was determined by western blot. (B) Nuclear translocation of NF-κB p65 in human macro-
phages stimulated with T. vaginalis (low) compared with medium alone (up). Human macrophages (5 × 106/cover glass) were incubated
with live T. vaginalis (1 × 106) for 30 min. Cells were then fixed and subjected to immunofluorescent microscopy after staining with anti-
NF-κB p65 Ab (Red) and DAPI (Green) to visualize nuclei. 
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Fig. 3. NO production (A) and iNOS expression (B) by HMDM stimulated with T. vaginalis (T). Human macrophages (1.25 × 106/well of
96-well culture plate) were incubated with live trichomonads (1.25 × 105), opsonized trichomonads (1.25 × 105), or T. vaginalis lysate
(100 μg/ml). NO was determined by the Griess reagent after 1 hr, 4 hr, and 24 hr of incubation (A). For identification of iNOS expression,
human macrophages (1.25 × 106/well) were incubated with live trichomonads (1.25 × 105) for 1 hr. The iNOS expression was examined
by western blot with anti-iNOS Ab (B). *P < 0.05 versus untreated macrophages. 
Fig. 4. Effects of L-NMMA (an iNOS inhibitor) on NF-κB activity of human macrophages induced by T. vaginalis. L-NMMA-preteated
HMDM or THP-1 cells was stimulated with live T. vaginalis. NF-κB activities were determined by western blot (A) or luciferase assay (B).
Human macrophages were coincubated with live trichomonads (macrophage : trichomonads = 5 : 1) for 2 hr, and then western blot was
done with rabbit anti-phospho NF-κB p65 monoclonal Ab (A). The PCH110 and PGL3 NF-κB promoter constructs were transfected into
THP-1 cells with LipofectAmine 2000. Luciferase activity was assayed with a luciferase assay kit. Cell extracts obtained from THP-1 cells
stimulated with live trichomonads for 1 hr were prepared in 500 μl of 1 × reporter lysis buffer. The luciferase activity was measured with a
Luminometer (B).
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Fig. 5. Effects of L-NMMA on TNF-αproduction in HMDM cells induced by live T. vaginalis. L-NMMA-pretreated macrophage suppressed
T. vaginalis-triggered TNF-αexpression, measured by RT-PCR (A) and ELISA (B), respectively. *P < 0.05 versus macrophages stimulat-
ed with T. vaginalis. 
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DISCUSSION
In this study, human macrophages were shown to be involved
in vaginal inflammation by T. vaginalis via proinflammatory
cytokine and NO production. In addition, TNF-αinduced by
live trichomonads in macrophages might be regulated through
NO-dependent activation of NF-κB. Our results are consistent
with previous reports in which macrophages infected with vari-
ous protozoan parasites, such as Trypanosoma congolense, Eimeria
bovis, Leishmania chagasi, and Leishmania donovani, showed in-
creased expressions of many inflammatory mediators, such as
cytokines, chemokines, and NO [13-16]. 
NO is gaseous water and lipid-soluble molecule that is one
of the most widespread signaling molecules in mammals. NO
is implicated in modulating a variety of physiological reactions,
including vasodilation and smooth muscle relaxation associat-
ed with the circulation, functioning as a neurotransmitter in var-
ious neural processes, and regulation of immunological defense
mechanisms [17]. The role of NO in inflammation and inflam-
matory responses remains unclear [18]. However, it is known
that NO production in human macrophages differs from the
rodent macrophages and the regulation of macrophage NO in
humans appears to be a more selective and variable process than
that seen in the rodent macrophages [19]. 
Human macrophage in the study showed increased levels of
NO by stimulation with T. vaginalis after 24 hr of coincubation.
The iNOS expression in HMDM by T. vaginalis was also about
6 times higher than the control group, however, trichomonad-
induced iNOS levels were inhibited by pretreatment with NO
synthase inhibitor, L-NMMA, suggesting that NO plays a signif-
icant role in immune responses by T. vaginalis.
It is widely known that NF-κB is normally present in the cyto-
sol and exists as an inactive complex with a class of inhibitory
proteins, known as inhibitor κB (IκB) proteins. Following an
inflammatory stimulus, the phosphorylation of IκB triggers its
degradation and the translocation of NF-κB to the nucleus, where
it binds to promoter regions and induces the expression of a
wide variety of genes involved in inflammation, including those
encoding cytokines (such as IL-1, IL-6, and TNF-α), enzymes
(including NO synthase), adhesion molecules, and acute-phase
proteins [20]. Expectedly, in this study, we have demonstrated
similar results that involvement of NF-κB activation in the pro-
duction of cytokines, such as TNF-α, induced by T. vaginalis stim-
ulation was identified by nuclear translocation and phosphory-
lation of NF-κB p65 in human macrophages (Fig. 2). 
NO production is generally upregulated by some stimuli (in-
cluding LPS) known to induce iNOS gene expression via a NF-
κB-mediated pathway [21]. We found that human macrophages
pretreated with an iNOS inhibitor, L-NMMA, showed decreased
NF-κB activity and TNF-αproduction triggered by T. vaginalis
(Figs. 2-5), although the inhibitory effects of NF-κB inhibitor
on iNOS protein expression or NO production induced by T.
vaginalis was not checked in this study. Therefore, it is speculat-
ed that decreased iNOS levels with L-NMMA may occur through
suppressed NF-κB activities.
On the other hand, few reports have been shown about the
cytokine production regulated by NO; NO production activates
the release of cytokines, cytokine receptors, and adhesion mole-
cules [22-24]. The effect of NO on expression of TNF-αis reported
to be likely via activation of a TNF-α-converting enzyme (TACE),
which is responsible for membrane-bound TNF and thereby
activating release of this cytokine [22]. TNF-αproduction caused
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Fig. 6. Effects of iNOS inhibitor or NF-κB inhibitor on TNF-αproduction in macrophages induced by T. vaginalis. Pretreatment of human
macrophages (THP-1 or HMDM) with L-NMMA or NF-κB inhibitor (PDTC or Bay11-7082) showed significant reduction of trichomonad-
induced TNF-αproduction in THP-1 (A) and HMDM (B). Protein levels of TNF-αwere measured by ELISA. *P < 0.05 versus untreated
macrophages. �P < 0.05 versus T. vaginalis-stimulated macrophages.
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by T. vaginalis in the study was significantly decreased by pre-
treatment with L-NMMA in human macrophages, suggesting an
important role of NO in T. vaginalis-induced TNF-αproduction.
Our result is in line with a previous report by Huang et al. [25]
in that NO inhibitors decreased TNF-αsynthesis by an LPS-acti-
vated J774 macrophage cell line. In this study, we also found that
L-NMMA-pretreated macrophages reduced NF-κB activity. There-
fore, it is strongly suggested that T. vaginalis stimulates human
macrophages to produce TNF-αthrough NO-dependent activa-
tion of NF-κB. 
Neutrophil migration is a complex process, which results main-
ly from the release of neutrophil chemotactic factors by resident
cells. Apart from its importance in host defense, the migration
of neutrophils to the inflammatory site is, at least in part, respon-
sible for tissue damage observed in several inflammatory dis-
eases, such as rheumatoid arthritis, glomerulonephritis, and
inflammatory bowel disease [26,27]. In trichomoniasis, neu-
trophils are known to be the predominant inflammatory cells
found in the vaginal discharge of the patients. We previously
indicated that T. vaginalis-induced recruitment of neutrophils
may be mediated via CXC chemokine IL-8 [28]. IL-1β, TNF-α,
C5a, and lipid mediators, such as platelet-activating factor 4 and
leukotriene (LTB4), are known the main chemotactic mediators
involved in neutrophil recruitment to the sites of inflammation
[29]. Therefore, IL-1βand TNF-αproduced by macrophages stim-
ulated with T. vaginalis may play a crucial role in vivo as media-
tors of neutrophilic tissue recruitment at the infected sites in vagi-
nal trichomoniasis in women.
Our results showed that T. vaginalis caused human monocyte-
derived macrophage (HMDM) to produce proinflammatory
cytokines, such as IL-1, IL-6, TNF-α, and NO, via NF-κB. It is sug-
gested that human macrophages may be involved in inflamma-
tion caused by T. vaginalis via the cytokine and NO production. 
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